flow trial semaglutide renal outcomes 2024 Study: slowed progression of CKD, cut cardiovascular events, mortality risk π¨ Journal Club: FLOW Trial
Description
Semaglutide burping versus tirzepatide burping If semaglutide burping is unbearable, you might wonder whether switching to tirzepatide would help
The total taper takes 12 to 14 weeks
Impaired tissue repair: Slower regeneration in skin, muscles, and organs
The boxed warning concerns C-cell tumors (medullary thyroid carcinoma), not nodule formation
In other words, the genomic effects of thyroid hormone cause your heart to beat stronger
